Mathot et al. assess stability of an adenovirus-based vaccine vector lyophilized and stored long-term. The stability of the vaccine remains within an acceptable limit after five years of storage ...

According to the latest information published by the World Health Organization, there are two vaccines in clinical trials against coronavirus. These are an adenovirus vector-based vaccine being ...

The number of suspected cases of this neurological condition reported from the region has crossed 101. Why is it happening ...

Recurrent respiratory papillomatosis (RRP) is a disease of the upper airway presenting with exophytic wart-like lesions. These lesions are considered benign with less than a 1–5% chance of malignant ...

Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced that the U.S. Food and Drug Administration (FDA) has ...

For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) ...

The development of the technologies underlying current adenovirus and mRNA vaccines took decades. A key reason why COVID-19 vaccines were developed so quickly was because scientists had already ...

Suresh Mittal, Distinguished Professor of Virology in the College of Veterinary Medicine, presented “Universal Influenza Vaccine — An Aspiration or Reality?” at the Westwood Lecture Series on Jan. 28.

Fearless journalism is more important than ever. When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world ...

Around the same time, a senior in Louisiana was diagnosed with the first "severe" case in the U.S. As bird flu continues to ramp up, many are wondering what tools—namely, vaccines—we have to ...